Cargando…

Anti-MDA5 Antibody Dermatomyositis Overlap with Systemic Lupus Erythematosus: A Case Report and Review of the Literature

BACKGROUND: Dermatomyositis (DM) is an autoimmune connective tissue disease that primarily targets the muscle, skin, and lungs. Many patients have autoantibodies that correspond to distinct clinical phenotypes. Melanoma differentiation-associated gene 5 (anti-MDA5) antibody, a specific antibody that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milam, Emily C., Futran, Jacobo, Franks Jr., Andrew G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204063/ https://www.ncbi.nlm.nih.gov/pubmed/28077979 http://dx.doi.org/10.2174/1874312901610010122

Ejemplares similares

Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity
por: Chen, Qiuhe, et al.
Publicado: (2022)

Anti-MDA5 Antibody-Associated Clinically Amyopathic Dermatomyositis: Case Report and Literature Review
por: Kersey, Cooper B., et al.
Publicado: (2021)

Overlap Syndrome-Systemic Sclerosis, Systemic Lupus Erythematosus and Dermatomyositis - Case Report
por: CIRSTEA, C., et al.
Publicado: (2015)

7. Anti-MDA5 associated dermatomyositis
por: Laverty, Ursula, et al.
Publicado: (2019)

Editorial: Anti-MDA5-Positive Dermatomyositis
por: Gono, Takahisa, et al.
Publicado: (2022)

My-Lupus: A case of anti-transcriptional intermediary factor 1-gamma antibody-positive dermatomyositis overlapping with discoid lupus erythematosus in an adult patient
por: Toker, Michelle, et al.
Publicado: (2023)

On the Nose: Anti-MDA-5 Dermatomyositis Manifesting as Perinasal Swelling
por: Molina, Emily, et al.
Publicado: (2022)

Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis
por: Labrador-Horrillo, Moises, et al.
Publicado: (2014)

Anti-MDA5 antibody-positive dermatomyositis presenting as unilateral eyelid edema
por: Chen, Lauren, et al.
Publicado: (2020)

Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
por: Nombel, Anaïs, et al.
Publicado: (2021)

Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis
por: Li, Liubing, et al.
Publicado: (2017)

Painless Panniculitis upon the Treatment of Clinically Amyopathic Dermatomyositis with Anti-MDA5 Antibody
por: Kishida, Dai, et al.
Publicado: (2021)

Cutaneous Features of Anti-MDA-5 Antibody-Positive Amyopathic Dermatomyositis in a Sudanese Patient
por: Alqahtani, Nouf, et al.
Publicado: (2021)

82 Juvenile dermatomyositis with early-onset anti-MDA 5 antibodies: a case report
por: Ayad, N, et al.
Publicado: (2022)

Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
por: Ida, Tomoaki, et al.
Publicado: (2023)

Machine learning for screening and predicting the risk of anti-MDA5 antibody in juvenile dermatomyositis children
por: Xue, Yuan, et al.
Publicado: (2023)

Anti‐MDA5 and anti‐SSA/Ro52 antibodies double‐positive dermatomyositis overlapping with rheumatoid arthritis‐associated interstitial lung disease: A case report
por: Xiong, Hong, et al.
Publicado: (2022)

Advancements in the Treatment of Cutaneous Lupus Erythematosus and Dermatomyositis: A Review of the Literature
por: Elhage, Kareem G, et al.
Publicado: (2022)

Anti-MDA5 Amyopathic Dermatomyositis—A Diagnostic and Therapeutic Challenge
por: Bobirca, Anca, et al.
Publicado: (2022)

Subcutaneous Calcinosis in a Patient with Anti-MDA5 Positive Dermatomyositis
por: Hou, Ruihong, et al.
Publicado: (2021)

Pathogenesis of anti-melanoma differentiation-associated gene-5 (MDA5) dermatomyositis
por: Weng, Chenghua, et al.
Publicado: (2022)

Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
por: Ikeda, Satoshi, et al.
Publicado: (2015)

Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial Symptom
por: Hattori, Yuki, et al.
Publicado: (2018)

Association of Cytomegalovirus Infection With Anti-MDA5 Antibody-Positive Dermatomyositis: A Prospective Cohort Study
por: Huang, Linlin, et al.
Publicado: (2021)

Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
por: Aissaoui, Houari, et al.
Publicado: (2021)

Infection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study
por: Billet, Anne-Claire, et al.
Publicado: (2022)

Spontaneous Intramuscular Hemorrhage in Anti-MDA5 Positive Dermatomyositis: A Case Series and Literature Review
por: Xu, Zhangling, et al.
Publicado: (2022)

Dermatomyositis Which Was Double Positive for Anti-MDA5 and Anti-ARS Antibodies That Was Successfully Treated by Intensive Immunosuppressive Therapy
por: Hama, Satoshi, et al.
Publicado: (2022)

Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies
por: Hiramatsu, Toshiya, et al.
Publicado: (2022)

Anti-MDA-5 Dermatomyositis With Development of Drug-Mediated Necrolytic Skin Lesions
por: Case, Robert A., et al.
Publicado: (2020)

Seasonal Effect on Disease Onset and Presentation in Anti-MDA5 Positive Dermatomyositis
por: So, Ho, et al.
Publicado: (2022)

Cardiac involvement in anti-MDA5 dermatomyositis: a case-based review
por: Quintero-González, Diana C., et al.
Publicado: (2022)

Case Report: Anti-MDA-5 dermatomyositis in a resource-limited setting
por: Risal, Ujjwol, et al.
Publicado: (2023)

Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease: report of two cases
por: Mehta, Asmita A, et al.
Publicado: (2021)

Successful peficitinib addition on anti-MDA5 antibody-positive dermatomyositis refractory to triple therapy and glucocorticoid reduction
por: Oba, Yuki, et al.
Publicado: (2022)

Pneumomediastinum in MDA5-associated clinically amyopathic dermatomyositis
por: Kotsiou, Ourania S., et al.
Publicado: (2017)

Therapiealternativen bei amyopathischer MDA5-positiver Dermatomyositis
por: Schumacher, Falk, et al.
Publicado: (2023)

Anti-melanoma Differentiation-Associated Gene 5 (Anti-MDA5) Dermatomyositis: A Case Presentation
por: Ruppel, Tyler, et al.
Publicado: (2022)

Macrophage activation syndrome in MDA5 antibody-positive dermatomyositis and COVID-19 infection
por: Keshtkarjahromi, Marzieh, et al.
Publicado: (2021)

The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients
por: Chen, Xixia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t0orp2mat0icdcip4rqbcimil1